Pathways that were distinct to IFNβ + LPS treatment in adipocytes included class I MHC processing and presentation, adaptive and innate immune system, PI3K/AKT activation, impaired glucose tolerance, increased adipocyte glucose uptake, and regulation of glucose transmembrane transport (Fig. 2f). This evidence concerns the gene IFNB1 and Impaired glucose tolerance.